Study guide
7.3 Temperature Control & Targeted Temperature Management (TTM)
AHA ACLS Provider Advanced Cardiovascular Life Support
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: BLS & High-Quality CPR Foundation
1.1 Chest Compression Mechanics & Performance Metrics 1.2 Chest Compression Fraction & Interruptions 1.3 Two-Rescuer Rotation & Fatigue Prevention 1.4 AED Operation & Special Resuscitation Circumstances
2 Chapter 2: ACLS Adult Cardiac Arrest Algorithm
2.1 Cardiac Arrest Recognition & Systematic Approach 2.2 VF/pVT Management & Defibrillation Energy Protocols 2.3 Asystole & PEA Management 2.4 Epinephrine Dosing & Pharmacodynamics in Arrest 2.5 Antiarrhythmic Drugs: Amiodarone & Lidocaine in Refractory VF/pVT 2.6 Reversible Causes of Arrest: The H's 2.7 Reversible Causes of Arrest: The T's 2.8 Physiological Monitoring & CPR Quality Metrics
3 Chapter 3: Bradycardia Algorithm
3.1 Symptomatic Bradycardia Assessment & Instability Criteria 3.2 Atropine Dosing, Indications & Block Limitations 3.3 Transcutaneous Pacing (TCP) Operation & Management 3.4 Chronotropic Infusion Therapies: Dopamine & Epinephrine
4 Chapter 4: Tachycardia Algorithm
4.1 Tachycardia Triage: Stable vs. Unstable Assessment 4.2 Synchronized Cardioversion Indications, Energy Doses & Sync Mechanics 4.3 Stable Narrow-Complex Tachycardia: Vagal Maneuvers & Adenosine Protocol 4.4 Stable Wide-Complex Tachycardia & Antiarrhythmic Infusions 4.5 Polymorphic VT (Torsades de Pointes) & Magnesium Sulfate Protocol
5 Chapter 5: Acute Coronary Syndrome (ACS)
5.1 ACS Identification, EMS & ED Triage 5.2 Initial ED & Prehospital Pharmacotherapy 5.3 STEMI vs. NSTE-ACS Risk Stratification & Biomarkers 5.4 Reperfusion Strategies & Quality Benchmark Time Goals
6 Chapter 6: Acute Ischemic Stroke
6.1 Stroke Recognition & Out-of-Hospital Assessment 6.2 Emergency Department Evaluation & Diagnostic Time Goals 6.3 Fibrinolytic Therapy & Blood Pressure Management 6.4 Endovascular Therapy (EVT) & Post-Acute Care
7 Chapter 7: Post–Cardiac Arrest Care
7.1 Immediate Post-ROSC Airway & Respiratory Optimization 7.2 Hemodynamic Management & MAP Optimization 7.3 Temperature Control & Targeted Temperature Management (TTM) 7.4 Emergent Coronary Angiography & Multimodal Neuroprognostication
8 Chapter 8: Airway Management & Pharmacology
8.1 Basic Airway Adjuncts & Bag-Mask Ventilation 8.2 Advanced Airways: Supraglottic Devices & Endotracheal Intubation 8.3 Continuous Waveform Capnography 8.4 ACLS Emergency Drug Reference & Administration Routes
9 Chapter 9: High-Performance Team Dynamics & Special Circumstances
9.1 High-Performance Team Dynamics & Communication 9.2 Resuscitation Debriefing & Quality Improvement Metrics 9.3 Special Arrest Circumstances: Cardiac Arrest in Pregnancy 9.4 Special Arrest Circumstances: Opioids, Anaphylaxis, Drowning & Hypothermia
7.3 Temperature Control & Targeted Temperature Management (TTM)
Key Takeaways Explain This Topic AI
2025 AHA post–cardiac arrest temperature control is indicated for adults who remain unresponsive to verbal commands after ROSC.
Choose either hypothermic temperature control (32–34°C) or normothermic/fever-prevention control (36–37.5°C) and keep the selected strategy consistent.
Maintain temperature control for at least 36 hours—the shortest recommended duration in the 2025 AHA Guidelines Highlights.
Suppress shivering aggressively and, when rewarming from hypothermia, use a controlled rate of about 0.25–0.5°C per hour.
Last updated: July 2026
Temperature Control & Targeted Temperature Management (TTM)
Quick Answer (2025 AHA): For adult patients who remain unresponsive to verbal commands after ROSC, maintain temperature control for at least 36 hours . Temperature control includes hypothermic temperature control (32–34°C) or normothermic/fever-prevention temperature control (36–37.5°C) . Keep the chosen strategy consistent, suppress shivering, and rewarm slowly when leaving a hypothermic target.
Post-anoxic brain injury is the leading cause of death and long-term disability after successful resuscitation. Ischemia–reperfusion injury triggers excitotoxicity, calcium overload, oxidative stress, mitochondrial injury, and neuroinflammation. Temperature control—historically taught as Targeted Temperature Management (TTM) or therapeutic hypothermia—blunts these pathways, lowers cerebral metabolic demand, and prevents fever-related secondary injury.
Why the 2025 Guidelines Emphasize "Temperature Control"
The 2025 American Heart Association Guidelines for CPR and ECC update post–cardiac arrest temperature language to temperature control , recognizing that both controlled hypothermia and active fever prevention are valid neuroprotective strategies. The Highlights document states it is reasonable to maintain temperature control for at least 36 hours in adults who remain unresponsive to verbal commands after ROSC. That 36-hour figure is the shortest recommended total duration of temperature control, not an optional early stop after 24 hours.
Clinicians studying for ACLS still encounter the term TTM in courses and algorithms. Treat TTM as the operational label for implementing temperature control: select a strategy, monitor core temperature continuously, prevent shivering, and avoid uncontrolled fever.
Indications and Patient Selection
Initiate temperature control for an adult who achieves ROSC but remains comatose , defined as absence of a meaningful response to verbal commands . Apply this recommendation regardless of:
- Initial rhythm (VF/pVT or asystole/PEA)
- Arrest location (OHCA or IHCA)
Patients who awaken promptly and follow commands do not need induced hypothermia, but fever prevention remains essential . Relative contraindications include severe uncontrolled hemorrhage, profound baseline hypothermia already below safe induction ranges, or goals-of-care directives that prioritize comfort over intensive neuroprotective therapy.
Two Evidence-Based Temperature Strategies (2025)
- Strategy Target range Clinical intent
- Hypothermic temperature control 32–34°C Controlled hypothermia to reduce cerebral metabolic demand
- Normothermic / fever-prevention control 36–37.5°C Prevent pyrexia and keep temperature tightly regulated
Either approach is acceptable under 2025 guidance. The clinical mandate is consistency : once a target strategy is chosen, avoid large fluctuations and do not oscillate between deep hypothermia and uncontrolled fever. Large comparative trials showed that preventing fever with a carefully controlled near-normothermic strategy can produce neurological outcomes comparable to deeper hypothermia in many cohorts—provided temperature is actively managed rather than left to chance.
Duration: At Least 36 Hours
Maintain temperature control for at least 36 hours . Older teaching often cited a 24-hour cooling plateau; the 2025 Highlights update the shortest recommended duration to 36 hours of total temperature control . Plan staffing, sedation, and monitoring around that minimum window.
Accurate core temperature monitoring is mandatory (esophageal probe, bladder thermistor, or pulmonary artery catheter). Axillary, oral, tympanic, and temporal measurements are too inaccurate to guide therapy.
Cooling Modalities and Induction
Intravascular cooling systems: Closed-loop central venous catheters with circulating coolant provide rapid induction and stable maintenance.
Surface cooling devices: Hydrogel pads or water-circulating blankets linked to automated feedback controllers.
Cold IV fluids for induction only: Ice-cold (4°C) crystalloid boluses (often ~30 mL/kg) can accelerate induction in EMS or ED settings, but should not be the sole long-term maintenance method and must be used cautiously in pulmonary edema or severe heart failure.
Shivering Control
Shivering increases heat production, oxygen consumption, and CO₂ generation, undoing neuroprotection. Use a tiered approach:
- Sedation and analgesia (e.g., propofol or midazolam plus a short-acting opioid)
- Anti-shivering adjuncts (magnesium, buspirone, acetaminophen, dexmedetomidine as locally protocolized)
- Neuromuscular blockade if shivering persists despite the above
Continuous EEG or train-of-four monitoring is warranted when paralysis is used so unrecognized seizures are not masked.
Controlled Rewarming and Late Fever Prevention
When leaving a hypothermic target, rewarm slowly—commonly 0.25–0.5°C per hour —to reduce vasodilation, electrolyte shifts, and rebound cerebral edema. Stop or carefully adjust potassium infusions before rewarming to avoid hyperkalemic arrest. After the temperature-control window, continue active fever prevention; late fever remains associated with worse secondary neuronal injury.
Exam Trap
Do not answer that temperature control ends at 24 hours. For ACLS written items aligned to 2025 science, the correct shortest recommended duration of post-ROSC temperature control in unresponsive adults is at least 36 hours , using either 32–34°C hypothermia or 36–37.5°C fever-prevention control.